Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Li, Roger; Shah, Paras H.; Stewart, Tyler F.; Nam, Jong Kil; Bivalacqua, Trinity J.; Lamm, Donald L.; Uchio, Edward M.; Geynisman, Daniel M.; Jacob, Joseph M.; Meeks, Joshua J.; Dickstein, Rian; Pearce, Shane M.; Kang, Seok Ho; Jung, Seung Il; Kamat, Ashish M.; Burke, James M.; Keegan, Kirk A.; Steinberg, Gary D.

doi:10.1038/s41591-024-03025-3

Nat Med

2024

DOI: 10.1038/s41591-024-03025-3

|View full text |Cite|

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Roger Li,

Paras H. Shah,

Tyler F. Stewart

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Bioinspired micro‐ and nanostructured systems for cancer therapy

Yang,

Zhang,

Fei

et al. 2024

MedComm

View full text Add to dashboard Cite

Numerous organisms in nature have demonstrated enhanced biocompatibility, precise tumor targeting capabilities, and efficient tissue traversal within the human body. Drawing inspiration from these organisms, researchers have employed bioengineering, bioconjugation, and micro‐ or nanotechnology to fabricate bioinspired micro‐ and nanostructured systems. These systems play a crucial role in addressing the limitations of conventional anticancer drugs and nanomaterials concerning biocompatibility, effective penetration of physiological barriers, as well as selective tumor targeting, thereby leading to improved therapeutic efficacy while minimizing nonspecific adverse effects on healthy cells. Consequently, extensive exploration of these bioinspired micro‐ and nanostructured systems has been undertaken across various cancer treatment modalities with some progressing into preclinical or clinical stages. However, our understanding of this field remains limited which may impede research progress, clinical translation efforts, and practical applications. Therefore, this study presents a systematic classification of bioinspired micro‐ and nanostructured systems for cancer therapy that comprehensively elucidates their sources of inspiration and design principles. Furthermore, it extensively discusses the current status of clinical translation efforts while identifying prevailing challenges and exploring future prospects. This work will establish a robust theoretical framework and serve as a valuable reference to facilitate advancements in research and clinical application within this field.

show abstract

Bioinspired micro‐ and nanostructured systems for cancer therapy

Yang,

Zhang,

Fei

et al. 2024

MedComm

View full text Add to dashboard Cite

show abstract

Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy

Choi,

Jeong,

Simó

et al. 2024

Nat Commun

View full text Add to dashboard Cite

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

Li,

Villa,

et al. 2024

Nat Med

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Cited by 6 publications

References 30 publications

Bioinspired micro‐ and nanostructured systems for cancer therapy

Bioinspired micro‐ and nanostructured systems for cancer therapy

Urease-powered nanomotor containing STING agonist for bladder cancer immunotherapy

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

Contact Info

Product

Resources

About